24.24
0.08%
+0.02
Castle Biosciences Inc (CSTL) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
7.52%
66.12
|
61.49 | 50.14 | 42.04 | 38.34 |
Cost Of Revenue |
9.75%
12.42
|
11.32 | 11.06 | 10.18 | 9.52 |
Gross Profit |
7.02%
53.70
|
50.17 | 39.08 | 31.86 | 28.82 |
Operating Expenses
|
0.77%
59.35
|
59.81 | 60.24 | 63.38 | 51.65 |
Interest Income/Expense |
0.00%
0.002
|
0.002 | 0.003 | 0.004 | 0.004 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
0.91%
71.78
|
71.13 | 71.30 | 73.56 | 61.17 |
Operating Income/Loss |
41.31%
-5.658
|
-9.64 | -21.16 | -31.52 | -22.83 |
Income/Loss From Continuing Operations Before Tax |
7.52%
66.12
|
61.49 | -18.78 | -29.20 | 38.34 |
Income Tax Expense/Benefit, Deferred |
-0.236
|
- | - | 0.013 | -0.038 |
Income Tax Expense/Benefit |
21.87%
0.039
|
0.032 | 0.016 | 0.014 | 0.057 |
Income/Loss From Continuing Operations After Tax |
62.64%
-2.58
|
-6.905 | -18.78 | -29.20 | -20.62 |
Net Income/Loss
|
62.64%
-2.58
|
-6.905 | -18.78 | -29.20 | -20.62 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.71%
0.077
|
26.83 | 26.73 | 26.61 | 0.116 |
Diluted Average Shares |
99.71%
0.077
|
26.83 | 26.73 | 26.61 | 0.116 |
Basic Earnings Per Share |
65.38%
-0.09
|
-0.26 | -0.70 | -1.10 | -0.79 |
Diluted Earnings Per Share |
65.38%
-0.09
|
-0.26 | -0.70 | -1.10 | -0.79 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):